The Feds are expanding their investigation into Medtronic’s off-label use of Infuse

Medtronic Bone-Growth Product Scrutinized (NY Times)

Feds Widening Infuse Inquiry (OTW)

The New York Times reported that the U.S. Justice Department (DOJ) criminal investigation into Medtronic’s off-label marketing of Infuse was “apparently widening.” Medtronic received the first subpoena from the DOJ looking into off-label use of InFuse in October 2006.